[go: up one dir, main page]

DK1119363T3 - Sammensætning, der indeholder carnetin- og inositolphosphat, egnet som kosttilskud eller lægemiddel - Google Patents

Sammensætning, der indeholder carnetin- og inositolphosphat, egnet som kosttilskud eller lægemiddel

Info

Publication number
DK1119363T3
DK1119363T3 DK00922866T DK00922866T DK1119363T3 DK 1119363 T3 DK1119363 T3 DK 1119363T3 DK 00922866 T DK00922866 T DK 00922866T DK 00922866 T DK00922866 T DK 00922866T DK 1119363 T3 DK1119363 T3 DK 1119363T3
Authority
DK
Denmark
Prior art keywords
carnetin
drug
composition containing
dietary supplement
inositol phosphate
Prior art date
Application number
DK00922866T
Other languages
English (en)
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of DK1119363T3 publication Critical patent/DK1119363T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
DK00922866T 1999-04-22 2000-04-19 Sammensætning, der indeholder carnetin- og inositolphosphat, egnet som kosttilskud eller lægemiddel DK1119363T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999RM000248A IT1306133B1 (it) 1999-04-22 1999-04-22 Composizione comprendente una carnitina ed un inositolfosfato, utilequale integratore dietetico o medicamento.

Publications (1)

Publication Number Publication Date
DK1119363T3 true DK1119363T3 (da) 2005-10-17

Family

ID=11406708

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00922866T DK1119363T3 (da) 1999-04-22 2000-04-19 Sammensætning, der indeholder carnetin- og inositolphosphat, egnet som kosttilskud eller lægemiddel

Country Status (26)

Country Link
US (1) US6565876B1 (da)
EP (1) EP1119363B1 (da)
JP (1) JP2002542282A (da)
KR (1) KR20010053023A (da)
CN (1) CN1359295A (da)
AR (1) AR023391A1 (da)
AT (1) ATE299370T1 (da)
AU (1) AU776591B2 (da)
BR (1) BR0006076A (da)
CA (1) CA2335015C (da)
DE (1) DE60021247T2 (da)
DK (1) DK1119363T3 (da)
EE (1) EE200000742A (da)
ES (1) ES2243254T3 (da)
HU (1) HU227357B1 (da)
IL (1) IL140164A0 (da)
IS (1) IS5763A (da)
IT (1) IT1306133B1 (da)
NO (1) NO20006429L (da)
PL (1) PL197885B1 (da)
PT (1) PT1119363E (da)
SI (1) SI1119363T1 (da)
SK (1) SK19322000A3 (da)
TN (1) TNSN00083A1 (da)
TR (1) TR200003737T1 (da)
WO (1) WO2000064426A2 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1316997B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento di vasculopatie,che comprende propionil l-carnitina e coenzima q10.
DE10032964B4 (de) * 2000-07-06 2017-10-12 Beiersdorf Ag Verwendung von Kreatin in kosmetischen oder dermatologischen Zubereitungen
DE10129502A1 (de) * 2001-06-19 2003-01-09 Beiersdorf Ag Verwendung von Carnitin und/oder einem oder mehreren Acyl-Carnitinen zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Steigerung der Ceramidbiosynthese
US8173618B2 (en) * 2003-07-25 2012-05-08 University Of Massachusetts Formulations for reducing neuronal degeneration
US20090169585A1 (en) * 2003-10-23 2009-07-02 Resveratrol Partners, Llc Resveratrol-Containing Compositions And Their Use In Modulating Gene Product Concentration Or Activity
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
CA2601641A1 (en) * 2005-03-18 2006-09-28 Oxyplus, Inc. Calcium salt of myo-inositol 1,6:2,3:4,5 tripyrophosphate as an allosteric effector of hemoglobin
ES2280136B1 (es) * 2006-02-17 2008-08-16 Universitat De Les Illes Balears Asociacion a dosis fija de fitato y zinc.
JP5281268B2 (ja) * 2007-10-31 2013-09-04 花王株式会社 筋力向上剤
US8597640B2 (en) * 2007-10-31 2013-12-03 University Of Massachusetts Lowell Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging
KR20110083628A (ko) * 2008-11-11 2011-07-20 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이. 셀룰라이트의 치료에 유용한 화합물
SG10201503032UA (en) * 2010-06-16 2015-06-29 Sigma Tau Ind Farmaceuti Acetyl-carnitine for use in a method for increasing neurogenesis in neural tissue
ES2495666B1 (es) * 2013-03-15 2015-08-10 Laboratoris Sanifit, S.L. Uso de derivados con enlaces c-o-p en pacientes con fallo renal
KR102141971B1 (ko) * 2018-11-12 2020-08-06 주식회사 노암 항암용 조성물
US20220226286A1 (en) * 2019-05-23 2022-07-21 Ekyj Consulting Ii, Llc Compositions and methods for the treatment and mitigation of alcohol-induced skin flushing

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5626849A (en) * 1995-06-07 1997-05-06 Reliv International, Inc. Weight loss composition for burning and reducing synthesis of fats
EP1021177A4 (en) * 1997-02-04 2002-05-15 John V Kosbab COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF VASCULAR DEGENERATIVE DISEASES
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US5904924A (en) * 1997-11-04 1999-05-18 Oncologics, Inc. Green nutritional powder composition

Also Published As

Publication number Publication date
CA2335015C (en) 2008-03-18
KR20010053023A (ko) 2001-06-25
WO2000064426A2 (en) 2000-11-02
ITRM990248A1 (it) 2000-10-22
IS5763A (is) 2000-12-08
AU4313500A (en) 2000-11-10
HUP0102926A2 (hu) 2002-03-28
EE200000742A (et) 2002-04-15
SI1119363T1 (en) 2005-10-31
ATE299370T1 (de) 2005-07-15
DE60021247T2 (de) 2006-04-27
IT1306133B1 (it) 2001-05-30
AU776591B2 (en) 2004-09-16
TR200003737T1 (tr) 2001-07-23
NO20006429D0 (no) 2000-12-15
WO2000064426A3 (en) 2001-05-25
DE60021247D1 (de) 2005-08-18
AR023391A1 (es) 2002-09-04
PL346160A1 (en) 2002-01-28
EP1119363B1 (en) 2005-07-13
US6565876B1 (en) 2003-05-20
CA2335015A1 (en) 2000-11-02
TNSN00083A1 (fr) 2005-11-10
JP2002542282A (ja) 2002-12-10
SK19322000A3 (sk) 2001-06-11
HUP0102926A3 (en) 2002-12-28
BR0006076A (pt) 2001-03-20
HU227357B1 (en) 2011-04-28
ES2243254T3 (es) 2005-12-01
PL197885B1 (pl) 2008-05-30
CN1359295A (zh) 2002-07-17
PT1119363E (pt) 2005-09-30
NO20006429L (no) 2001-02-20
EP1119363A2 (en) 2001-08-01
IL140164A0 (en) 2002-02-10

Similar Documents

Publication Publication Date Title
HUP0104195A3 (en) Vitamin d analogues, preparation thereof, pharmaceutical and cosmetic compositions containing them
DK1119363T3 (da) Sammensætning, der indeholder carnetin- og inositolphosphat, egnet som kosttilskud eller lægemiddel
IL148876A0 (en) Sulfonamide derivatives, their preparation and pharmaceutical compositions containing them
HUP0100225A3 (en) Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them
AU2003246810A1 (en) Diphenylpyridine derivatives, the preparation thereof, and pharmaceutical compositions containing said derivatives
NO20006318D0 (no) Farmasöytiske formuleringer for aerosoler med to eller flere aktive stoffer
HUP0102766A3 (en) Aminomethylcarboxylic acid derivatives, their pharmaceutical use and pharmaceutical compositions comprising them
HUP0000851A3 (en) Novel pyrimidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
HUP0004226A3 (en) Novel vitamin d analogues, pharmaceutical compositions containing thereof and process for preparing the same
EE04151B1 (et) Atsüülpiperasinüülpürimidiinide derivaadid, nendevalmistamine ja kasutamine ravimitena
EE200100661A (et) Leeliselist sfingomüelinaasi sisaldav kompositsioon kasutamiseks dieteetilise valmistise, toidulisandi või farmatseutilise tootena
AU2841199A (en) Novel bis-benzamide derivatives, method for making same pharmaceutical compositions containing them and use thereof as medicine
PL344984A1 (en) Artemisinin derivatives, method for the preparation thereof and pharmaceutical compositions containing the same
IL148807A0 (en) Tetrahydrothiopyran derivatives and pharmaceutical compositions containing the same
HUP0200468A3 (en) Resorcinol derivatives and pharmaceutical compositions containing them
DK1106174T3 (da) Sammensætninger der indeholder fedtoplöselige vitaminer
HRP980576B1 (en) Sulphonamide substituted benzopyran derivatives, process for their preparation, their use as medicines and pharmaceutical compositions containing them
AU4543200A (en) Pharmaceutical or cosmetic compositions for the local, intradermal application of hormones
NO20014692L (no) 3-amidinobenzensulfonamidderivater, medisinske sammensetninger inneholdende slike samt intermediater vedfremstillingen derav
HUP0202305A2 (en) Novel vitamin d analogues, process for their preparation and pharmaceutical compositions containing them
AU3041499A (en) Ginkgolide derivatives, preparation method and pharmaceutical compositions containing them
HUP0203454A3 (en) Novel fusidic acid derivatives, pharmaceutical compositions containing them and their use
HUP0202594A3 (en) Streptogramin derivatives, production thereof and pharmaceutical compositions containing the same
IL143800A0 (en) Halovir, an antiviral marine natural product, derivatives thereof and pharmaceutical compositions containing the same
BR1100782A (pt) Fenilimidazolidinas substituìdas, sua aplicação como medicamentos e as composições farmacêuticas que as contêm